Search Results - "Mead, Graham P."
-
1
Use of Nonclonal Serum Immunoglobulin Free Light Chains to Predict Overall Survival in the General Population
Published in Mayo Clinic proceedings (01-06-2012)“…Abstract Objective To determine whether the free light chain (FLC) assay provides prognostic information relevant to the general population. Methods After…”
Get full text
Journal Article -
2
Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease
Published in Clinical journal of the American Society of Nephrology (01-11-2008)“…Monoclonal free light chains (FLC) frequently cause kidney disease in patients with plasma cell dyscrasias. Polyclonal FLC, however, have not been assessed in…”
Get full text
Journal Article -
3
Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma : In vitro and in vivo studies
Published in Journal of the American Society of Nephrology (01-03-2007)“…Of patients with newly diagnosed multiple myeloma, approximately 10% have dialysis-dependent acute renal failure, with cast nephropathy, caused by monoclonal…”
Get full text
Journal Article -
4
Assessment of Monoclonal Gammopathies by Nephelometric Measurement of Individual Immunoglobulin κ/λ Ratios
Published in Clinical chemistry (Baltimore, Md.) (01-09-2009)“…Currently, monoclonal immunoglobulins are identified and quantified from bands on electrophoretic gels. As an alternative, clonality might be determined by…”
Get full text
Journal Article -
5
Serum test for assessment of patients with Bence Jones myeloma
Published in The Lancet (British edition) (08-02-2003)“…Bence Jones protein in urine (immunoglobulin free-light-chains) is characteristic of light-chain multiple myeloma. We aimed to compare a quantitative…”
Get full text
Journal Article -
6
Highly Sensitive, Automated Immunoassay for Immunoglobulin Free Light Chains in Serum and Urine
Published in Clinical chemistry (Baltimore, Md.) (01-04-2001)“…Bence Jones proteins or monoclonal immunoglobulin kappa and lambda free light chains (FLCs) are important markers for identifying and monitoring many patients…”
Get full text
Journal Article -
7
Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma
Published in Blood (01-05-2001)“…Using sensitive, automated immunoassays, increased concentrations of either κ or λ free light chains (and abnormal κ/λ ratios) were detected in the sera of 19…”
Get full text
Journal Article -
8
Overestimation of serum kappa free light chain concentration by immunonephelometry
Published in Clinical chemistry (Baltimore, Md.) (01-09-2010)Get full text
Journal Article -
9
Frequency of altered monoclonal protein production at relapse of multiple myeloma
Published in British journal of haematology (01-02-2010)Get full text
Journal Article -
10
Quantitative assessment of serum and urinary polyclonal free light chains in patients with type II diabetes: an early marker of diabetic kidney disease?
Published in Expert opinion on therapeutic targets (01-06-2008)“…Free light chains (FLCs) are bi-products of normal immunoglobulin synthesis and are predominately removed from the circulation by the kidneys. This study…”
Get more information
Journal Article -
11
Reply to “Pediatric reference intervals for immunoglobulin G and its subclasses with Siemens immunonephelometric assays”
Published in Clinical biochemistry (01-06-2011)Get full text
Journal Article -
12
Serum free light chain immunoassay as an adjunct to serum protein electrophoresis and immunofixation electrophoresis in the detection of multiple myeloma and other B-cell malignancies
Published in Clinical chemistry and laboratory medicine (01-03-2009)“…Protein and immunofixation electrophoresis of serum and urine are established as diagnostic aids for identifying monoclonal gammopathies. However, many patient…”
Get more information
Journal Article -
13
The tumor kinetics of multiple myeloma following autologous stem cell transplantation as assessed by measuring serum-free light chains
Published in Leukemia & lymphoma (2006)“…In multiple myeloma, changes in serum-free immunoglobulin light chains (FLC) are a more rapid indicator of treatment response than intact immunoglobulin due to…”
Get full text
Journal Article -
14
Measurement of immunoglobulin free light chains in serum
Published in Clinical chemistry (Baltimore, Md.) (01-11-2003)Get full text
Journal Article -
15
Overestimation of Serum [kappa] Free Light Chain Concentration by Immunonephelometry/In Reply
Published in Clinical chemistry (Baltimore, Md.) (01-09-2010)“…All authors confirmed they have contributed to the intellectual content of this paper and have met the following 3 requirements: (a) significant contributions…”
Get full text
Journal Article -
16
Assessment of Monoclonal Gammopathies by Nephelometric Measurement of Individual Immunoglobulin {kappa}/{lambda} Ratios
Published in Clinical chemistry (Baltimore, Md.) (01-09-2009)“…Currently, monoclonal immunoglobulins are identified and quantified from bands on electrophoretic gels. As an alternative, clonality might be determined by…”
Get full text
Journal Article -
17
Serum free light chains for monitoring multiple myeloma/Response to: Serum free light chains for monitoring multiple myeloma
Published in British journal of haematology (01-02-2005)Get full text
Journal Article -
18
Monoclonal Gammopathy as a Determinant of Adverse Outcomes in Patients with Chronic Kidney Disease
Published in Blood (16-11-2006)“…Elevated serum free light chain (sFLC) concentrations are associated with glomerular and tubulointerstitial disease. We have analyzed a cohort of patients with…”
Get full text
Journal Article -
19
Serum free light chains for monitoring multiple myeloma
Published in British journal of haematology (01-02-2005)Get full text
Journal Article -
20
Serum Free Light Chain (SFLC) Concentration Kinetics in Patients Receiving Bortezomib: Temporary Inhibition of Protein Synthesis and Early Biomarker for Disease Response
Published in Blood (16-11-2005)“…Monoclonal intact immunoglobulin is detectable in the serum of approximately 80% of myeloma patients while SFLC are found to be abnormal in the serum of…”
Get full text
Journal Article